DRESS syndrome (drug rash with eosinophilia and systemic symptoms): sometimes, not all signs are there
Abstract
DRESS syndrome is a rare and potentially fatal multisystemic reaction that occurs two to six weeks after exposure to certain drugs. It is characterized by fever, eosinophilia, and skin rash. Case of a 37-year-old man, black, with gout (started allopurinol 4 weeks before). He arrived at the Emergency Room complaining of headache, fever, abdominal pain, and scattered maculopapular skin lesions. The conducted study showed elevated transaminases and C-reactive protein, hepatomegaly, and peri-hepatic adenomegalies. Allopurinol was stopped, but throughout hospitalization, liver, renal and neurological dysfunctions (with meningoencephalitis) worsened; it also appeared eosinophilia. A skin biopsy was performed, the possibility of DRESS syndrome was assumed, and methylprednisolone 2 mg/kg/day was started, with progressive improvement. The skin biopsy was compatible with DRESS. The described case reveals some peculiarities. Among the most relevant arethe late onset of eosinophilia and the difficulty in evaluating the rash due to the patient's skin tone and neurological manifestations (rare).
Keywords
References
- Isaacs M, Cardones R, Rahnama-Moghadam S. Dress syndrome: clinical myths and pearls. Cutis 2018;102:322-6.
- Adwan MH. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and the rheumatologist. Curr Reumathol Rep 2017;19:1-9. DOI: https://doi.org/10.1007/s11926-017-0626-z
- Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 2013;169:1071-80. DOI: https://doi.org/10.1111/bjd.12501
- Behera S, Das S, Xavier A, Selvarajan S. DRESS syndrome: a detailed insight. Hospital Pract 2018;46:152-62. DOI: https://doi.org/10.1080/21548331.2018.1451205
- Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part II. Management and therapeutics. J Am Acad Dermatol 2013;68:709.e1-9. DOI: https://doi.org/10.1016/j.jaad.2013.01.032
- Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med 2011;124:588-97. DOI: https://doi.org/10.1016/j.amjmed.2011.01.017
- Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effect of drugs with systemic symptoms: Does DRESS syndrome really exist? Br J Dermatol 2007;156:609-11. DOI: https://doi.org/10.1111/j.1365-2133.2006.07704.x
- Corneli HM. DRESS syndrome: drug reaction with eosinophilia and systemics symptoms. Pediatr Emerg Care 2017;33:499-504. DOI: https://doi.org/10.1097/PEC.0000000000001188
- Gonçalo M, Coutinho I, Teixeira V, et al. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population. Br J Dermatol 2013;169:660-5. DOI: https://doi.org/10.1111/bjd.12389
- LaHood N, Sokol K. DRESS syndrome associated with splenic thrombosis. Ann Allergy Asthma Immunol 2017;119:463-4. DOI: https://doi.org/10.1016/j.anai.2017.08.288
- Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part I. Clinical perspectives. J Am Acad Dermatol 2013;68:693.e1-14. DOI: https://doi.org/10.1016/j.jaad.2013.01.033
- Masaki T, Fukunaga A, Tohyama M, et al. Human herpes virus 6 encephalitis in allopurinol-induced hypersensitivity syndrome. Acta Derm Venereol 2003;83:128-31. DOI: https://doi.org/10.1080/00015550310007481
- Gaha M, Landry D, Bélair M, et al. DRESS syndrome: cerebral vasculitic-like presentation. Neuroradiology 2015;57:1015-21. DOI: https://doi.org/10.1007/s00234-015-1562-0
- Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003;206:353-6. DOI: https://doi.org/10.1159/000069956
- Chen YC, Chang CY, Cho YT, et al. Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: A retrospective cohort study from Taiwan. J Am Acad Dermatol 2013;68:459-65. DOI: https://doi.org/10.1016/j.jaad.2012.08.009
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2021 the Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.